William Aliski's Net Worth

$15.8 Million

Estimate Recalculated Apr 19, 2024 03:38PM EST

Who is William Aliski?

William Aliski has an estimated net worth of $15.8 Million. This is based on reported shares across multiple companies, which include Ultragenyx Pharmaceutical Inc., APPLIED GENETIC TECHNOLOGIES CORP, and X4 Pharmaceuticals, Inc.

SEC CIK

William Aliski's CIK is 0001598426

Past Insider Trading and Trends

2018 was William Aliski's most active year for acquiring shares with 8 total transactions. William Aliski's most active month to acquire stocks was the month of May. 2018 was William Aliski's most active year for disposing of shares, totalling 6 transactions. William Aliski's most active month to dispose stocks was the month of October. 2021 saw William Aliski paying a total of $790,875.00 for 33,770 shares, this is the most they've acquired in one year. In 2020 William Aliski cashed out on 45,000 shares for a total of $2,473,047.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Ultragenyx Pharmaceutical Inc. (RARE) Snapshot price: $44.875

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+3.32%
2.15K
—
—
66.85K
Jun 24
Form 4
-1.52%
-1.00K
$123.43
-$383,700.00
64.7K
Feb 19 - Feb 23
Form 4
—
0
$72.66
-$139,150.00
57.02K
Aug 21
Form 4
+4.68%
2.55K
—
—
57.02K
Jun 26
Form 4
-22.14%
-20.00K
$74.02
-$1,480,322.00
70.35K
May 18
Form 4
—
0
$57.51
-$257,100.00
47.92K
May 18
Form 4
+6.68%
3K
—
—
47.92K
Jun 11
Form 4
-6.23%
-6.00K
$49.69
-$298,140.00
90.35K
Scheduled
Dec 7
Form 4
-5.86%
-6.00K
$55.67
-$334,020.00
96.35K
Scheduled
Nov 8
Form 4
+25.73%
65.42K
$66.78
-$1,417,097.50
319.7K
Scheduled
Feb 5 - Oct 8
Form 3/A
—
0
—
—
0
Form 4
-4.91%
-3.75K
$76.66
-$287,475.00
72.61K
Aug 8
Form 4
+4.09%
3K
—
—
76.36K
Jun 19
Form 4
+18.59%
11.5K
$21.00
$241,500.00
73.36K
Jan 23
Form 4
+3.13%
1.88K
—
—
61.86K
Jun 22
Form 4
—
0
$49.60
-$343,160.00
59.98K
Dec 5
Form 4
+3.23%
1.88K
—
—
59.98K
Jun 9
Form 4
—
0
—
—
0
Jun 18
Form 4
-9.09%
-6.00K
$42.16
-$252,942.20
60.01K
Dec 4
Form 4
+78.88%
29.11K
$3.01
$87,615.08
66.01K
Oct 20
Form 4
—
0
—
—
0
Jul 10
Form 4
—
0
—
—
0
Feb 5
Form 4
+15.67%
5K
$21.00
$105,000.00
36.9K
Jan 30
Form 3
—
0
—
—
0
No matching records found

APPLIED GENETIC TECHNOLOGIES CORP No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-8.50K
—
—
0
Nov 30
Form 4
—
0
—
—
0
Nov 30
Form 4
—
0
—
—
0
Dec 16
Form 4
—
0
—
—
0
Dec 4
Form 4
+240.00%
6K
$3.25
$19,477.00
8.5K
Dec 14
Form 4
—
0
—
—
0
Nov 15
Form 4
—
0
—
—
0
Sep 20
Form 3
—
0
—
—
0
No matching records found

X4 Pharmaceuticals, Inc (XFOR) Snapshot price: $0.8539

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+674.97%
45K
—
—
51.67K
Jun 13
Form 4
∞
6.67K
—
—
6.67K
Jun 6
Form 4
—
0
—
—
0
Jun 2
Form 4
—
0
—
—
0
Jun 10
Form 4
—
0
—
—
0
Sep 18
Form 3
—
0
—
—
0
No matching records found